Objetivo: Abordar as diferentes facetas do cuidado de pacientes com neoplasias cutâneas a partir dos pilares que sustentam o cuidado centralizado no paciente, incluindo multidisciplinariedade, cooperação entre equipes e especialização.
Público-alvo: Dermatologistas, oncologistas clínicos, radio oncologistas e cirurgiões oncológicos, além de acadêmicos e profissionais de saúde interessados no diagnóstico e tratamento dos tumores cutâneos.
Local:
Sírio-Libanês de Ensino e Pesquisa
Rua Professor Daher Cutait, 69 – Bela Vista - São Paulo – SP – Brasil
Dates:
Scientific symposium – April, 2nd and 3rd 2020 - New dates soon
International Guests:
- Alexander Eggermont (Surgical Oncology)
- Sanjiv Agarwala (Clinical Oncology)
- Joseph Malvehy (Dermatology)
Scientific Committee:
Professor Alexander Eggermont is appointed CSO of the Princess Máxima Center for pediatric oncology from October 1, 2019. He will be succeeding professor Hans Clevers, who stepped down on June 1. For the past nine years Eggermont has been General Director of Gustave Roussy Cancer Campus Grand Paris, the famous oncological healthcare and research institute in France. Here, he developed Europe’s largest Phase 1-2 drug development and immunotherapy development program amongst others.
As a Chairman of the Melanoma Unit at the Hospital Clinic of Barcelona, and dermatologist devoted to research and clinical management of patients with melanocytic lesions, Dr. Malvehy emphasizes the importance of projects promoting research, teaching
and advice to families affected with congenital nevi. He is convinced that working with many other professionals and patient associations will help improve the quality of life of patients.
Hospital Clinic de Barcelona, Barcelona, Spain
Dermatology, oncology
Sanjiv Agarwala, MD, is Professor of Oncology at Temple University School of Medicine, in Philadelphia. He is nationally and internationally recognized as an expert in the research and treatment of melanoma and immunotherapy of cancer and has presented and led numerous conferences and meetings across the globe. He has written and contributed to over 200 publications and book chapters on melanoma, immune-oncology and other research areas and has been principal investigator for multiple clinical trials involving immunotherapy and targeted therapy for melanoma, head & neck and renal cancer and other malignancies. He has received several honors, including listings as one of America’s top doctors for cancer and best doctors in the United States.
|
13:30-13:38 |
Opening |
Francisco Belfort |
|
|
Module – Hot topics in melanoma – a multidisciplinary approach Chairs: José Antonio Sanches and Claudia Regina de Oliveira |
|||
|
13:40-13:58 |
A closer look into current scenario and trends in melanoma epidemiology - why are the numbers increasing? |
Jade Martins |
|
|
14:00-14:18 |
The impact of awareness campaigns – are they effective? |
Flávio Cavarsan |
|
|
14:20-14:38 |
The role of circulating DNA in the management of melanoma |
Mariana Petaccia |
|
|
14:40-14:58 |
Cutting-edge imaging techniques in melanoma |
Luciana Zattar |
|
|
15:00-15:18 |
Current applications of tele-dermatoscopy and how this approach will shape de future |
Josep Malvehy |
|
|
15:20-15:40 |
Discussion / Q&A |
||
|
15:40-16:10 |
Interval / Coffee Break |
||
|
Plenary session – Day 1 Chairs: Luiza Dib and Fábio Ferreira |
|||
|
16:10-16:40 |
Plenary 1 – Perioperative systemic treatment in melanoma – updates and perspectives |
Alexander Eggermont |
|
|
16:40-17:10 |
Plenary 2 – The current role of microscopically controlled surgery in cutaneous malignancies |
Josep Malvehy |
|
|
17:10-17:30 |
Roundtable and Q&A |
||
|
17:30-17:40 |
Closure – Day 1 |
|
|
|
Module: Challenges in the management of melanoma Chairs: Alberto Wainstein and Luis Fernando Tovo |
||
|
08:30-08:48 |
Hereditary syndromes in melanoma and indications for investigation of germline mutations |
Maria Isabel Achatz |
|
08:50-09:08 |
Surgical approaches to anatomically unfavorable melanomas |
Eduardo Bertolli |
|
09:10-09:28 |
Skin cancer in the elderly – not the same patients |
Theodora Karnakis |
|
09:30-10:00 |
Roundtable: multidisciplinary approach to patients receiving BRAF/MEK inhibitors and ICP – what to expect and how to manage AEs? |
Reumato Roberto Kalil Daniel Ciampi Rodrigo Munhoz Reinaldo Tovo Allan Pereira |
|
10:00-10:30 |
Interval / Coffee Break |
|
|
Module: Case-based roundtables Chairs: Rodrigo Munhoz and Marina Sahade |
||
|
10:30-11:00
|
Case 1: Adjuvant melanoma – I recommend ICP |
Andreia Melo |
|
Case 1: Adjuvant melanoma – I recommend TT |
Milton Barros |
|
|
Case 1: Discussion |
Alexander Eggermont, Andreia Melo, Milton Barros, Luiz Flávio Coutinho |
|
|
11:00-11:30
|
Case 2: Management of patients with oligometastatic disease |
Fabio Ferreira |
|
Case 2: Discussion |
Fabio Ferreira, Sanjiv Agarwala, Samir Abdallah Hanna, Francisco Belfort, Abner Barrozo, Rodrigo Villarroel |
|
|
11:30-12:00
|
Case 3: Management of SCC and BCC – optimal initial approach |
Reinaldo Tovo |
|
Case 3: Discussion |
Vera de Barros / Ana Maria Sortino / Antonio Sérgio Zafred Marcelino / Flávio Cavarsan / Fábio Ferreira / Francisco Belfort / Josep Malvehy |
|
|
12:00-12:40 |
Satellite symposium 1 |
|
|
12:40-13:20 |
Satellite symposium 2 |
|
|
Plenary session – Day 2 Chairs: Cristina Abdalla and Francisco Belfort |
||
|
13:30-14:00 |
Plenary 3 - Which melanoma patients should still undergo surgery? From localized do advanced disease |
Alexander Eggermont |
|
14:00-14:30 |
Plenary 4 - Beyond current standards – what to expect for patients with advanced melanoma? |
Sanjiv Agarwala |
|
14:30-14:50 |
Roundtable and Q&A |
|
|
14:50-15:20 |
Interval / Coffee Break |
|
|
Module: Non-melanoma skin cancers Chairs: Frederico Teixeira Jr and Melissa Fugimori |
||
|
15:20-15:38 |
Overview: advances in the systemic treatment of cSCC and BCC |
Rodrigo Guedes |
|
15:40-15:58 |
Roundtable: management of locally advanced squamous cell carcinomas and basal cell carcinomas |
Marina Sahade / Felice Riccardi / Sergio Couto/ João Luis Fernandes / Luis Fernando Tovo / Tatiana Strava |
|
16:00-16:18 |
Merkel cell carcinoma – treatment updates and opportunities for perioperative approaches |
Rafael Schmerling |
|
16:20-16:30 |
Discussion / Q&A |
|
|
Module: Areas of uncertainty Chairs: André Molina and Eduardo Akaishi |
||
|
16:30-16:48 |
What is the optimal surgical approach to patients with clinically involved LN? |
Alexander Eggermont |
|
16:50-17:08 |
Challenges in particular melanocytic lesions: form melanosis to Spitzoid tumours. |
Josep Malvehy |
|
17:10-17:28 |
Melanoma and pregnancy – risks and management |
Miguel Brandão |
|
17:30-17:48 |
Combining IO and RT – where are we? |
Samir Abdallah Hanna |
|
17:50-18:00 |
Discussion / Q&A |
|
|
18:00 |
Closure |
|
Receba as informações sobre os cursos e eventos Sírio-Libanês Ensino e Pesquisa.